Leif Bergsagel, MD


Accepting PhD Students

  • 21763 Citations
  • 80 h-Index
1984 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 7 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Plasma Cells Medicine & Life Sciences
Dexamethasone Medicine & Life Sciences
Tumors Chemical Compounds
Therapeutics Medicine & Life Sciences
Cell Line Medicine & Life Sciences
Receptor, Fibroblast Growth Factor, Type 3 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1997 2020

Monoclonal Gammopathy of Undetermined Significance
Plasma Cells
Multiple Myeloma
Bone Neoplasms

Mayo Clinic Multiple Myeloma SPORE

Fonseca, R., Stewart, A. K., Dueck, A., Chesi, M., Bergsagel, P. L., Chesi, M. & Dueck, A.

National Institutes of Health


Project: Research projectSpecialized Center

Multiple Myeloma
Oncolytic Virotherapy
Clonal Evolution
Vesicular Stomatitis
Multiple Myeloma
Cell Line
Clustered Regularly Interspaced Short Palindromic Repeats

Molecular Pathogenesis of Multiple Myeloma

Bergsagel, P. L.

National Institutes of Health


Project: Research projectResearch Project

Multiple Myeloma
Disease Progression
Drug Resistance

Research Output 1984 2018

A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma

Sonbol, M. B., Hilal, T., Dueck, A., Rosenthal, A. C., Conley, C. R., Kosiorek, H. E., Ginos, B. F., Gano, K. M., Nichols, C. S., Leis, J. F., Johnston, P. B., Habermann, T. M., Northfelt, D. W., Bergsagel, P. L., Inwards, D. J., Witzig, T. E., Ansell, S. M. & Reeder, C. B., Jan 11 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Peripheral Nervous System Diseases
4 Citations

Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression

Kawano, Y., Zavidij, O., Park, J., Moschetta, M., Kokubun, K., Mouhieddine, T. H., Manier, S., Mishima, Y., Murakami, N., Bustoros, M., Pistofidis, R. S., Reidy, M., Shen, Y. J., Rahmat, M., Lukyanchykov, P., Karreci, E. S., Tsukamoto, S., Shi, J., Takagi, S., Huynh, D. & 7 othersSacco, A., Tai, Y. T., Chesi, M., Bergsagel, P. L., Roccaro, A. M., Azzi, J. & Ghobrial, I. M., Jun 1 2018, In : Journal of Clinical Investigation. 128, 6, p. 2487-2499 13 p.

Research output: Contribution to journalArticle

Interferon Type I
Immunosuppressive Agents
Multiple Myeloma
Regulatory T-Lymphocytes

Detailing the genomic landscape of myeloma

Bergsagel, P. L. & Michael Kuehl, W., Aug 9 2018, In : Blood. 132, 6, p. 554-555 2 p.

Research output: Contribution to journalReview article

Multiple Myeloma
1 Citations
Multiple Myeloma
Precision Medicine
Genetic Predisposition to Disease
1 Citations

Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment

Nakamura, K., Kassem, S., Cleynen, A., Chrétien, M. L., Guillerey, C., Putz, E. M., Bald, T., Förster, I., Vuckovic, S., Hill, G. R., Masters, S. L., Chesi, M., Bergsagel, P. L., Avet-Loiseau, H., Martinet, L. & Smyth, M. J., Jan 1 2018, (Accepted/In press) In : Cancer Cell.

Research output: Contribution to journalArticle

Multiple Myeloma